Topics:

Nuclear Imaging

PET Imaging with Amyvid for Alzheimer's

Video: Roberto Soto, MD, discusses his experience with PET imaging with Amyvid for Alzheimer’s evaluation, including reimbursement, training, and benefits of the new test.

Nuclear Imaging

PET with [18 F]flutemetamol can assist physicians in early and more accurate diagnosis of early onset dementia.

Brain PET and age may help clinicians determine which patients with amnestic mild cognitive disorder may progress on to probable Alzheimer’s disease.

Cardiac imaging with PET and MRI shows excellent diagnostic accuracy compared with SPECT-MPI.

18F-FDG PET more accurate than fMRI and may help physicians better determine the long-term recovery of patients with unresponsive wakefulness syndrome.

Calgary Scientific’s ResolutionMD received FDA clearance for diagnosis on mobile devices for most imaging modalities.

Pages

Subscribe to Nuclear Imaging on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.